Skip to contentM
Merit Medical Systems Inc
M
MMSIMerit Medical Systems Inc Q2 2021 · 10-Q
Revenue$280.33M$280.33M+28.4% vs Q2 2020 Net Income$4.92M$4.92MN/M vs Q2 2020 EPS Diluted$0.09$0.09N/M vs Q2 2020 Gross Profit$124,139,000+47.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Merit Medical Systems Inc · CIK 856982 · Engraved from SEC EDGAR
Operating Cash Flowderived$41,208,000−7.1% Free Cash Flowderived$34,562,000+6.3% Margins · derivedGross margin44.3%+5.7 pt vs Q2 2020
Operating margin3.2%+11.9 pt vs Q2 2020
Net margin1.8%+10.5 pt vs Q2 2020
ended Jun 30, 2021 · filed Aug 6, 2021 · 37 d after period end